Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Orange, CA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Stanford, CA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Aurora, CO
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Gainesville, FL
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Miami, FL
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Orlando, FL
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Tampa, FL
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Atlanta, GA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Boise, ID
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Boise, ID
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Glenview, IL
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Glenview, IL
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Iowa City, IA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Lexington, KY
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Louisville, KY
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Portland, ME
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Portland, ME
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Boston, MA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Worchester, MA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Worchester, MA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Detriot, MI
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Detriot, MI
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Grand Rapids, MI
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Minneapolis, MN
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Kansas City, MO
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
St. Louis, MO
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
St. Louis, MO
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Hanover, NH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Hanover, NH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Manchester, NH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Manchester, NH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Albuquerque, NM
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Albany, NY
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Hawthorne, NY
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
New Hyde Park, NY
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
New York, NY
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Cleveland, OH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Columbus, OH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Dayton, OH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Toledo, OH
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Oklahoma City, OK
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Hershey, PA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Charleston, SC
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Knoxville, TN
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Memphis, TN
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Nashville, TN
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Austin, TX
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Dallas, TX
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
San Antonio, TX
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Colchester, VT
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Colchester, VT
Click here to add this to my saved trials
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Richmond, VA
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
A Phase 2, Randomized, Double-blind, Placebo-controlled, Repeat-dose Study of KB001-A in Subjects With Cystic Fibrosis Infected With Pseudomonas Aeruginosa
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials